MATTIELLO, Luigi

MATTIELLO, Luigi  

Mostra records
Risultati 1 - 20 di 82 (tempo di esecuzione: 0.042 secondi).
Titolo Data di pubblicazione Autore(i) File
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 1992 TROVATI M; BURZACCA S; MULARONI E; MASSUCCO P; CAVALOT F; MATTIELLO L; ANFOSSI G
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 1991 Anfossi G; Mularoni E; Trovati M; Massucco P; Cavalot F; Mattiello L; Emanuelli G.
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 2012 Russo I; Barale C; Chirio M; Secchi M; Viretto M; Doronzo G; Mattiello L; Pagliarino A; Cavalot F; Valle M; Anfossi G; Trovati M.
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 2014 Russo I;Viretto M;Doronzo G;Barale C;Mattiello L;Anfossi G;Trovati M
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 2012 Doronzo G; Viretto M; Russo I; Mattiello L; Barale C; Vaccheris C; Anfossi G; Trovati M.
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 2002 G. ANFOSSI; RUSSO I.; MASSUCCO P.; MATTIELLO L.; CAVALOT F.; BALBO A.; TROVATI M.
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 2013 Russo I; Barale C; Chirio M; Secchi M; Viretto M; Doronzo G; Mattiello L; Pagliarino A; Cavalot F; Anfossi G; Trovati M.
Arginine vasopressin release from human platelets after irreversible aggregation. 1990 ANFOSSI G; MULARONI E; TROVATI M; MASSUCCO P; MATTIELLO L; EMANUELLI G.
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 2011 Russo I; Frascaroli C; Mattiello L; Viretto M; Barale C; Doronzo G; Di Martino L; Trovati M; Anfossi G.
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 2005 DORONZO G; RUSSO I; MATTIELLO L; TROVATI M; ANFOSSI G.
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 1991 G. ANFOSSI; MULARONI E; MASSUCCO P; CAVALOT F; BURZACCA S; MATTIELLO L; TROVATI M.
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 2002 ANFOSSI G; RUSSO I; MASSUCCO P; MATTIELLO L; M. TROVATI
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 2002 RUSSO I; MASSUCCO P; MATTIELLO L.; CAVALOT F.; G. ANFOSSI; TROVATI M.
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 1990 TROVATI M; G. ANFOSSI; MULARONI E; MASSUCCO P; CAVALOT F; MATTIELLO L; EMANUELLI G.
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 1993 G. ANFOSSI; MASSUCCO P; MULARONI E; MATTIELLO L; CAVALOT F; BURZACCA S; TROVATI M.
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 1991 ANFOSSI G; TROVATI M; MULARONI E; MASSUCCO P; CAVALOT F; MATTIELLO L; EMANUELLI G
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 1994 G. ANFOSSI; MASSUCCO P; MULARONI E; CAVALOT F; MATTIELLO L; TROVATI M.
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 2012 Doronzo G; Viretto M; Russo I; Mattiello L; Anfossi G; Trovati M.
GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide. 2013 Russo I; Barale C; Mattiello L; Cavalot F; Trovati M.
GLP-1 influences the inhibitory effects of nitric oxide on platelets. 2013 Russo I; Barale C; Mattiello L; Cavalot F; Trovati M.